CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
CytoDyn Inc.
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026
- Market cap
- $345.56M
- P/E (TTM)
- –
- Dividend yield
- –
CytoDyn Inc. revenue by segment
By business segment
By product or service
By region
From the segment and revenue-disaggregation notes of CytoDyn's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.